+
Instructors can request access to the Casebook Instructor's Guide on AccessPharmacy. Email User Services (userservices@mheducation.com) for more information.
++
After completing this case study, the reader should be able to:
++
Identify patients who require treatment for dyslipidemia.
Stratify individual patients for risk of coronary heart disease (CHD) and stroke.
Determine appropriate LDL and non-HDL goals and thresholds based on individual risk factors.
Recommend a cholesterol management strategy that includes therapeutic lifestyle changes (TLC), drug therapy, patient education, and monitoring parameters.
++
“I am here to see if I need additional meds.”
++
Thomas Smith is a 52-year-old man who presents to pharmacotherapy for optimization of risk reduction therapy clinic by referral from his primary care provider following an ST-elevation myocardial infarction (STEMI) 6 months ago. He reports good adherence to his medications since having his heart attack.
++
++
++
++
Chronic kidney disease (stage 3) × 5 years
++
CAD, s/p STEMI 6 months ago (drug-eluting stents placed in right circumflex and left anterior descending arteries)
++
++
Father: age 72 with MIs at age 50 and again at age 60
++
Mother: age 70 with no major medical conditions noted
++
Patient has one older brother age 55 with HTN and a history of one MI at the age of 48.
++
++
Patient is married and lives with his wife.
++
College graduate, works as an accountant.
++
Admits to drinking one to two beers most days of the week and has never used tobacco.
++
Exercise regimen has increased since his MI; currently rides the bike at the gym for 30 minutes 2–3 days a week.
+++
Meds (Per medication fill history)
++
++
Atorvastatin 80 mg PO once daily
++
Aspirin 81 mg PO once daily
++
Clopidogrel 75 mg PO once daily
++
Pantoprazole 40 mg PO once daily
++
Lisinopril 40 mg PO daily
++
Chlorthalidone 25 mg PO daily
++
Acetaminophen 500 mg, one to two tablets PO PRN every 6 hours for pain
++
++
++
Patient states that he had a heart attack ...